Log In
Print this Print this

Procaspase-activating compound (PAC-1)

  Manage Alerts
Collapse Summary General Information
Company Vanquish Oncology Inc.
DescriptionSmall molecule that activates procaspase -3 to caspase-3
Molecular Target Procaspase-3 ; Caspase-3 (CASP3) (CPP32)
Mechanism of ActionApoptosis stimulator
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today